Plan Sponsors Still Covering Humira Are Overpaying By Adam Berkowitz Humira (WAC): $6,922 After Rebate: $4,922 Amjevita: $1,385 Yusimry: $995 Abrilada: $1,038 Hadlima: $1,038 adalimumab-aaty: $275 Share Post Share